The Democratic Republic of Congo (DRC) has become the second African nation to sign a major bilateral health partnership with the United States, embracing a new financing model that emphasizes direct government-to-government cooperation and domestic investment. The five-year, $1.2 billion agreement, announced Thursday, follows a similar pact with Uganda and contrasts with rejections by Zambia and Zimbabwe over concerns about data sovereignty and conditionalities.
Under the 2026-2031 partnership, the DRC will receive $900 million in U.S. government assistance, contingent on its commitment to increase domestic health spending by $300 million. The funding targets HIV/AIDS, tuberculosis, malaria, maternal and child health, polio eradication, disease surveillance, workforce development, and emergency preparedness.
This deal is part of a broader U.S. strategic shift away from traditional multilateral aid channels toward structured bilateral compacts. These agreements require partner governments to co-finance health programs and establish formal frameworks for sharing health data. The model aims to foster greater national ownership and long-term sustainability of health systems.
However, the approach has sparked significant debate among African governments. Zambia recently declined a proposed $1.012 billion agreement after a draft memorandum surfaced detailing provisions that would grant the U.S. extended access to national health data and tie funding to strict performance metrics. Civil society groups there warned the terms could compromise national sovereignty and expose the health system to external leverage. Zimbabwe also exited negotiations on a $367 million pact, with officials calling the proposed terms “asymmetrical” and objecting to requirements to share biological samples and sensitive data without assured access to future medical products.
In contrast, Uganda’s government has endorsed its own $1.7 billion, five-year compact, framing it as a “sovereign-guided” model that strengthens national systems while maintaining control over health information.
The divergent responses highlight a central tension in the new U.S. global health financing strategy: balancing the push for accountability and domestic resource mobilization with partner nations’ concerns over data governance and equitable benefit-sharing. With the DRC now on board and two countries stepping back, the implementation of these compacts will test the boundaries of health diplomacy and sovereignty in Africa. The outcome may influence how other nations engage with similar bilateral funding frameworks in the future.
